Impaired glucose tolerance is associated with increased serum concentrations of interleukin 6 and co-regulated acute-phase proteins but not TNF-α or its receptors

作者: S. Müller , S. Martin , W. Koenig , P. Hanifi-Moghaddam , W. Rathmann

DOI: 10.1007/S00125-002-0829-2

关键词: EndocrinologyAcute-phase proteinInterleukin 6PopulationImmune systemImpaired glucose toleranceReceptorInflammationDiabetes mellitusInternal medicineMedicine

摘要: … associated immune network are acute-phase proteins for which … systemic concentrations of three major acute-phase proteins … We did not observe any increase of systemic TNF-α nor of …

参考文章(46)
L C Harrison, I L Campbell, A Wilson, A Cutri, Evidence for IL-6 production by and effects on the pancreatic beta-cell. Journal of Immunology. ,vol. 143, pp. 1188- 1191 ,(1989)
J. M. Mooy, P. A. Grootenhuis, H. de Vries, P. J. Kostense, C. Popp-Snijders, L. M. Bouter, R. J. Heine, Intra-individual variation of glucose, specific insulin and proinsulin concentrations measured by two oral glucose tolerance tests in a general Caucasian population: the Hoorn Study Diabetologia. ,vol. 39, pp. 298- 305 ,(1996) , 10.1007/BF00418345
Anders G. Olsson, Non-atherosclerotic disease and lipoproteins Current Opinion in Lipidology. ,vol. 2, pp. 206- 210 ,(1991) , 10.1097/00041433-199106000-00009
F De Benedetti, T Alonzi, A Moretta, D Lazzaro, P Costa, V Poli, A Martini, G Ciliberto, E Fattori, Interleukin 6 causes growth impairment in transgenic mice through a decrease in insulin-like growth factor-I. A model for stunted growth in children with chronic inflammation Journal of Clinical Investigation. ,vol. 99, pp. 643- 650 ,(1997) , 10.1172/JCI119207
Masahiko Shikano, Hiroshi Sobajima, Hiroto Yoshikawa, Takako Toba, Hiroko Kushimoto, Hideki Katsumata, Makoto Tomita, Shirou Kawashima, Usefulness of a highly sensitive urinary and serum IL-6 assay in patients with diabetic nephropathy. Nephron. ,vol. 85, pp. 81- 85 ,(2000) , 10.1159/000045634
Albrecht Hoffmeister, Dietrich Rothenbacher, Ute Bäzner, Margit Fröhlich, Hermann Brenner, Vinzenz Hombach, Wolfgang Koenig, Role of novel markers of inflammation in patients with stable coronary heart disease American Journal of Cardiology. ,vol. 87, pp. 262- 266 ,(2001) , 10.1016/S0002-9149(00)01355-2
H. Keen, R.J. Jarrett, P. McCartney, The ten-year follow-up of the Bedford survey (1962-1972): glucose tolerance and diabetes. Diabetologia. ,vol. 22, pp. 73- 78 ,(1982) , 10.1007/BF00254832
Bernhard Hellmich, Matthias Schellner, Helmut Schatz, Andreas Pfeiffer, Activation of transforming growth factor-β1 in diabetic kidney disease Metabolism-clinical and Experimental. ,vol. 49, pp. 353- 359 ,(2000) , 10.1016/S0026-0495(00)90264-6
N. SHERON, J. N. LAU, J. HOFMANN, R. WILLIAMS, G. J. M. ALEXANDER, Dose-dependent increase in plasma interleukin-6 after recombinant tumour necrosis factor infusion in humans Clinical and Experimental Immunology. ,vol. 82, pp. 427- 428 ,(2008) , 10.1111/J.1365-2249.1990.TB05465.X
A. Pfeiffer, J. Janott, M. Möhlig, M. Ristow, H. Rochlitz, K. Busch, H. Schatz, E. Schifferdecker, Circulating tumor necrosis factor alpha is elevated in male but not in female patients with type II diabetes mellitus. Hormone and Metabolic Research. ,vol. 29, pp. 111- 114 ,(1997) , 10.1055/S-2007-979001